Alemtuzumab Consolidation Does Not Improve Outcome for CLL Patients with High Risk Genomic Features on Successive CALGB Trials.
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Guido Marcucci |
| Publication date | November 18, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |